Clinical Trials in Baltimore

Showing 20521-20540 of 23,476 trials

Monoclonal Antibody Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer

NCT00004064

RATIONALE: Monoclonal antibodies can locate tumor cells and either kill them or deliver tumor-killing substances to them without harming normal cells. PURPOSE: Randomized phase II trial to study the effectiveness of monoclonal antibody therapy in treating patients who have ovarian, fallopian tube, or peritoneal cancer.

Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer

AltaRex102 participantsStarted Nov 1998

Newport Beach, California, United States • Fort Myers, Florida, United States • Orlando, Florida, United States +13 more locations

COMPLETEDPhase 2< 1 mile

Phase 2b Study of Cetuximab With Platinum-Based Chemo as First Line Treatment of Recurrent or Advanced NSCLC

NCT00828841

This study is testing the investigational drug, cetuximab, in combination with different chemotherapy drugs for lung cancer. The aim of the study is to determine which of the drug combinations looks most promising and should be tested further. The study will also look at what side effects may occur.

Non-Small Cell Lung Cancer

Accelerated Community Oncology Research Network601 participantsStarted Dec 2008

Anniston, Alabama, United States • Jonesboro, Arkansas, United States • Anaheim, California, United States +81 more locations

Monoclonal Antibody Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer

Phase 2b Study of Cetuximab With Platinum-Based Chemo as First Line Treatment of Recurrent or Advanced NSCLC

Find Trials by Condition in Baltimore

Multi-Analyte, Genetic, and Thrombogenic Markers of Atherosclerosis

Monoclonal Antibody Therapy in Treating Patients With Residual Disease From Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer Following Surgery and Chemotherapy

ONCONASE Plus Doxorubicin Versus Doxorubicin Alone For Patients With Malignant Pleural or Peritoneal Mesothelioma Who Have Had No More Than One Prior Chemotherapy Regimen

Eltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Subjects With Hepatitis C Related Liver Disease

Safety, Tolerability, and Antiviral Activity of 24 or 48 Weeks of GS-9190 in Combination With Peginterferon Alfa 2a and Ribavirin for the Treatment of Genotype-1 Chronic HCV Infection

Combivent® CFC Metered Dose Inhaler (MDI) in Moderate to Severe Asthma

Investigation of Efficacy, Safety and Tolerability of Once and Twice Daily Doses of AZD1981 in Asthmatic Patients

VNP40101M in Treating Patients With Relapsed or Refractory Locally Advanced or Metastatic Small Cell Lung Cancer

Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease

Carmustine in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme

A Comparison of the Effects of Tiotropium Inhalation qd and Salmeterol Inhalation Bid on Arterial Blood Gases.

Bortezomib, Ascorbic Acid, and Melphalan in Treating Patients With Newly Diagnosed Multiple Myeloma

Microwave Thermotherapy in Treating Women With Stage I or Stage II Breast Cancer

T4N5 Liposome Lotion Compared With Placebo Lotion for Preventing Actinic Keratoses in Patients With Xeroderma Pigmentosum

Vaccine Therapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer

The Primary Objective of This Study is to Determine Whether MICARDIS® Improves Insulin Sensitivity in Overweight or Obese, Non-diabetic, Normotensive Subjects

Radiation Therapy in Treating Patients With Stage I or Stage II Prostate Cancer

3-AP and Gemcitabine in Treating Patients With Metastatic Non-Small Cell Lung Cancer